TP53 and cervical carcinoma: An additional cell culture study from this group demonstrated that cervical cancer cells increase p53 levels in response to lopinavir [34], results consistent with our data (Figure 2b and Figure 3a) and potentially explained by our observations that protease inhibitors target and deplete E6 from HPV16-positive cell types (Figure 1, Figure 2b and Figure 3a).